Role of interleukin‐6 signalling in glucose and lipid metabolism
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Derangements in whole body glucose and lipid metabolism, accompanied by insulin resistance, are key features of obesity and the metabolic syndrome. A role for inflammation as a causative factor is an emerging concept in the field of metabolic disease. Research has centred on identifying important inflammatory markers, and tumour necrosis factor‐α has been highlighted as a key mediator of insulin resistance, as well as interleukin‐6 (IL‐6). A parallel ongoing endeavour is the unravelling of molecular mechanisms underlying the beneficial effects of physical exercise on whole body glucose and lipid metabolism. Release of IL‐6 from the contracting skeletal muscle has been proposed to be one of the molecular signals promoting the beneficial exercise‐induced effects. These two opposing views of IL‐6 underscore that the role of IL‐6 in whole body physiology is incompletely resolved. This review aims at summarizing the current data on mechanisms by which IL‐6 may impact on glucose and lipid metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 2×
“The incidence of obesity is growing dramatically in the United States, Europe and Worldwide (Li et al. 2006, WHO, 2006), which in turn is increasing the number of people with type 2 diabetes in an epidemic-like fashion (Zimmet et al. 2001).”
BackgroundC-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“IRS1 and PKB/Akt are critical nodes in the canonical insulin signalling pathway; a cascade of phosphorylation events initiated by insulin receptor autophosphorylation, and comprising a number of signalling molecules, including PI 3-kinase and AS160 (Glund & Zierath 2005, Taniguchi et al. 2006).”
BackgroundThe Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · cited 3×
“A less extreme elevation of IL-6 (six to ninefold over wildtype levels) resulted in a diabetic phenotype (Cai et al. 2005) or hepatic insulin resistance (Kim et al. 2004).”
BackgroundProtection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234 · cited 2×
“Some recent studies have highlighted that one of the main functions of IL-6 is to dampen the inflammatory response, primarily by suppressing the production of tumour necrosis factor-a (TNF-a) and IL-1b (Schindler et al. 1990, Tilg et al. 1994, Xing et al. 1998, Starkie et al. 2003, Steensberg et al. 2003).”
ResultImpaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193 · cited 1×
“In contrast, in lean first-degree relatives of type 2 diabetic subjects, insulin resistance is evident in the absence of any elevation in IL-6 levels compared to age, fitness and weight-matched controls (Petersen et al. 2004).”
BackgroundKern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · cited 2×
“Several different tissues contribute to basal circulating IL-6 levels, with up to 35% coming from adipose tissue (Mohamed-Ali et al. 1997, Kern et al. 2001).”
BackgroundInflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · cited 5×
“Mice with a targeted ablation of the IL-6 gene (IL-6) develop mature onset obesity and insulin resistance (Wallenius et al. 2002), indicating that the absence of IL-6 leads to characteristic features of the metabolic syndrome.”
BackgroundInfluentialIL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans
Steensberg, A., Fischer, C. P., Keller, C., Møller, K., & Pedersen, B. K. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00074.2003 · Cited by 1,135
Steensberg, A., van Hall, G., Osada, T., Sacchetti, M., Saltin, B., & Pedersen, B. K. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00237.x · Cited by 1,095 · cited 1×
“For example, during prolonged exercise, skeletal muscle becomes the predominant source and serum IL-6 levels increase dramatically (Steensberg et al. 2000).”
BackgroundRotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062 · cited 3×
“…3T3-L1 adipocytes, where IL-6 exerted inhibitory effects on differentiation and gene transcription of insulin receptor substrate (IRS)-1, insulinsensitive glucose transporter (GLUT) 4 and peroxsisome proliferator activated receptor (PPAR)-c (Rotter et al. 2003, Sopasakis et al. 2004).”
BackgroundSchindler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v75.1.40.40 · Cited by 1,012
Carey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm, G., Prelovsek, O., Hohnen-Behrens, C., Watt, M. J., James, D. E., et al. (2006) · Diabetes · doi:10.2337/db05-1404 · Cited by 898 · cited 4×
“Recent evidence indicates that IL-6 stimulation leads to an activation of AMPK in skeletal muscle (Kelly et al. 2004, Al-Khalili et al. 2006, Carey et al. 2006).”
BackgroundInfluentialInterleukin-6 induces cellular insulin resistance in hepatocytes.
Senn, J. J., Klover, P. J., Nowak, I. A., & Mooney, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.12.3391 · Cited by 883 · cited 2×
“…hepatocytes 0–8 h 20 ng mL)1 Reduced insulin receptor signal transduction and insulin action, inhibition of insulin-stimulated glycogen production Senn et al. (2002) Rat Primary hepatocytes 0–12 h 1 nmol L)1 Suppressed insulin effect on glycogen accumulation by inhibiting glycogen synthase…”
BackgroundMuscle‐derived interleukin‐6: mechanisms for activation and possible biological roles
FEBBRAIO, M. A., & PEDERSEN, B. K. (2002) · The FASEB Journal · doi:10.1096/fj.01-0876rev · Cited by 875 · cited 1×
“The exercise-induced increase in IL-6 has been proposed to act as a mediator of enhanced muscle metabolism and whole body insulin sensitivity (Febbraio & Pedersen 2002).”
BackgroundEtiology of Insulin Resistance
Petersen, K. F., & Shulman, G. I. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.009 · Cited by 825 · cited 1×
“…fatty acids are strongly correlated with skeletal muscle insulin resistance, and increased levels are observed in obesity and type 2 diabetes (Petersen & Shulman 2006), elevation of IL-6 in the absence of energy expenditure could possibly promote ectopic fat deposition in skeletal muscle.”
BackgroundTilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
Exercise and IL‐6 infusion inhibit endotoxin‐induced TNF‐α production in humans
Starkie, R., Ostrowski, S. R., Jauffred, S., Febbraio, M., & Pedersen, B. K. (2003) · The FASEB Journal · doi:10.1096/fj.02-0670fje · Cited by 790 · cited 1×
“…studies have highlighted that one of the main functions of IL-6 is to dampen the inflammatory response, primarily by suppressing the production of tumour necrosis factor-a (TNF-a) and IL-1b (Schindler et al. 1990, Tilg et al. 1994, Xing et al. 1998, Starkie et al. 2003, Steensberg et al. 2003).”
BackgroundInterleukin-6 stimulates lipolysis and fat oxidation in humans
van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., Hiscock, N., Møller, K., Saltin, B., Febbraio, M. A., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021687 · Cited by 767 · cited 2×
“A more consistent effect of IL-6 administration is an increase in lipid metabolism (van Hall et al. 2003, Petersen et al. 2005).”
BackgroundSubcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor- , in Vivo
Mohamed-Ali, V. (1997) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.82.12.4196 · Cited by 717
IL-6 signal transduction and its physiological roles: the signal orchestration model
Kamimura, D., Ishihara, K., & Hirano, T. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0012-2 · Cited by 673
Senn, J. J., Klover, P. J., Nowak, I. A., Zimmers, T. A., Koniaris, L. G., Furlanetto, R. W., & Mooney, R. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210689200 · Cited by 620 · cited 1×
“Studies in cultured hepatocytes have consistently reported an impairment of insulin action by IL-6 (Kanemaki et al. 1998, Senn et al. 2002, 2003).”
BackgroundDifferential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo
Kim, H.-J., Higashimori, T., Park, S.-Y., Choi, H., Dong, J., Kim, Y.-J., Noh, H.-L., Cho, Y.-R., Cline, G., Kim, Y.-B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1060 · Cited by 534
Chronic Exposure to Interleukin-6 Causes Hepatic Insulin Resistance in Mice
Klover, P. J., Zimmers, T. A., Koniaris, L. G., & Mooney, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.11.2784 · Cited by 488 · cited 3×
“The majority of evidence indicates that chronic elevations of IL-6 promote hepatic insulin resistance (Klover et al. 2003, 2005).”
BackgroundInterleukin-6 Is a Novel Factor Mediating Glucose Homeostasis During Skeletal Muscle Contraction
Febbraio, M. A., Hiscock, N., Sacchetti, M., Fischer, C. P., & Pedersen, B. K. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1643 · Cited by 455
IL-6 and TNF-α expression in, and release from, contracting human skeletal muscle
Steensberg, A., Keller, C., Starkie, R. L., Osada, T., Febbraio, M. A., & Pedersen, B. K. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00255.2002 · Cited by 410 · cited 1×
“During muscle contraction and exercise, IL-6 is released from the working muscle (Steensberg et al. 2002, Febbraio & Pedersen 2005, Pedersen & Febbraio 2005).”
BackgroundContraction-Induced Myokine Production and Release: Is Skeletal Muscle an Endocrine Organ?
Febbraio, M. A., & Pedersen, B. K. (2005) · Exercise and Sport Sciences Reviews · doi:10.1097/00003677-200507000-00003 · Cited by 402 · cited 1×
“During muscle contraction and exercise, IL-6 is released from the working muscle (Steensberg et al. 2002, Febbraio & Pedersen 2005, Pedersen & Febbraio 2005).”
BackgroundDose-Dependent Effects of Recombinant Human Interleukin-6 on Glucose Regulation
Tsigos, C., Papanicolaou, D. A., Kyrou, I., Defensor, R., Mitsiadis, C. S., & Chrousos, G. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4422 · Cited by 324 · cited 1×
“An acute in vivo increase in systemic IL-6 levels in healthy human subjects has been reported to either not affect (Petersen et al. 2005) or increase (Stouthard et al. 1995, Tsigos et al. 1997) plasma glucose levels (Table.”
BackgroundPetersen, E. W., Carey, A. L., Sacchetti, M., Steinberg, G. R., Macaulay, S. L., Febbraio, M. A., & Pedersen, B. K. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00257.2004 · Cited by 311
AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise.
Kelly, M., Keller, C., Avilucea, P. R., Keller, P., Luo, Z., Xiang, X., Giralt, M., Hidalgo, J., Saha, A. K., Pedersen, B. K., et al. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.05.188 · Cited by 289
Interleukin-6 depletion selectively improves hepatic insulin action in obesity.
Klover, P. J., Clementi, A. H., & Mooney, R. A. (2005) · Endocrinology · doi:10.1210/en.2004-1468 · Cited by 273
Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise
Jørgensen, S. B., Richter, E. A., & Wojtaszewski, J. F. P. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.109942 · Cited by 261
Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle
Al-Khalili, L., Bouzakri, K., Glund, S., Lönnqvist, F., Koistinen, H. A., & Krook, A. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0490 · Cited by 250 · cited 6×
“In cultured skeletal muscle cells, IL-6 directly increases glucose metabolism and enhances insulin action (Weigert et al. 2005, Al-Khalili et al. 2006).”
BackgroundResultInfluentialSelf-citationPedersen, B. K., & Febbraio, M. (2005) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2005.04.008 · Cited by 233 · cited 1×
“During muscle contraction and exercise, IL-6 is released from the working muscle (Steensberg et al. 2002, Febbraio & Pedersen 2005, Pedersen & Febbraio 2005).”
BackgroundMuscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects
Pedersen, B. K., Steensberg, A., Keller, P., Keller, C., Fischer, C., Hiscock, N., van Hall, G., Plomgaard, P., & Febbraio, M. A. (2003) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-002-0981-z · Cited by 228 · cited 1×
“Interleukin-6 (IL-6) is a 212-amino acid, 26 kDa cytokine that is involved in many biological processes, including inflammation and immune response (Pedersen et al. 2003, Hodge et al. 2005, Burkhard & Peter 2006), brain function (Balschun et al. 2004, Craddock & Thomas 2006) and fatigue…”
BackgroundInterleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle
Glund, S., Deshmukh, A., Long, Y. C., Moller, T., Koistinen, H. A., Caidahl, K., Zierath, J. R., & Krook, A. (2007) · Diabetes · doi:10.2337/db06-1733 · Cited by 219 · cited 1×
“Acute exposure of intact human skeletal muscle incubated in vitro leads to a modest but significant increase in glucose metabolism (Glund et al. 2007).”
BackgroundSelf-citationRieusset, J., Bouzakri, K., Chevillotte, E., Ricard, N., Jacquet, D., Bastard, J.-P., Laville, M., & Vidal, H. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2232 · Cited by 200 · cited 4×
“IRS1 and PKB/Akt are critical nodes in the canonical insulin signalling pathway; a cascade of phosphorylation events initiated by insulin receptor autophosphorylation, and comprising a number of signalling molecules, including PI 3-kinase and AS160 (Glund & Zierath 2005, Taniguchi et al. 2006).”
BackgroundInfluentialEnhanced muscle glucose metabolism after exercise: modulation by local factors
Richter, E. A., Garetto, L. P., Goodman, M. N., & Ruderman, N. B. (1984) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1984.246.6.e476 · Cited by 194 · cited 1×
“Early studies propose a skeletal muscle-derived factor mediates the enhanced insulin sensitivity observed in the hours immediately after exercise cessation (Goldstein et al. 1953, Garetto et al. 1984, Richter et al. 1984).”
BackgroundBruce, C. R., & Dyck, D. J. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00150.2004 · Cited by 178
Sleep enhances IL‐6 trans‐signaling in humans
Dimitrov, S., Lange, T., Benedict, C., Nowell, M. A., Jones, S. A., Scheller, J., Rose‐John, S., Born, J., Dimitrov, S., Lange, T., et al. (2006) · The FASEB Journal · doi:10.1096/fj.06-5754fje · Cited by 115 · cited 1×
“Interestingly, the expression of sIL-6R also increases during sleep, suggesting a widening of the profile of IL-6 actions on peripheral tissues and brain during sleep (Dimitrov et al. 2006).”
BackgroundSkeletal muscle and insulin sensitivity: pathophysiological alterations
Ryder, J. (2001) · Frontiers in bioscience · doi:10.2741/ryder · Cited by 73 · cited 1×
“Physical exercise affects skeletal muscle gene expression, metabolism and insulin sensitivity, as well as whole body insulin sensitivity (Ryder et al. 2001, Hawley et al. 38 2008 The Authors Journal compilation 2008 Scandinavian Physiological Society, doi: 10.1111/j.1748-1716.2007.01779.x 2006,…”
BackgroundInfluentialIL-6 increases muscle insulin sensitivity only at superphysiological levels
Geiger, P. C., Hancock, C., Wright, D. C., Han, D.-H., & Holloszy, J. O. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00701.2006 · Cited by 36 · cited 1×
“Acute exposure to IL-6 modestly enhanced glucose uptake in rat epitrochlearis muscle, but not in the soleus muscle (Geiger et al. 2007).”
Background
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Pedersen, B. K. (2011) · Journal of Experimental Biology · doi:10.1242/jeb.048074 · Cited by 668
Cardiovascular comorbidity in rheumatic diseases
Nurmohamed, M. T., Heslinga, M., & Kitas, G. D. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.112 · Cited by 325
Varma, V., Yao-Borengasser, A., Rasouli, N., Nolen, G. T., Phanavanh, B., Starks, T., Gurley, C., Simpson, P., McGehee, R. E., Kern, P. A., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90885.2008 · Cited by 229
Edward F. Adolph Distinguished Lecture: Muscle as an endocrine organ: IL-6 and other myokines
Pedersen, B. K. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00734.2009 · Cited by 215
“The findings suggesting that IL-6 is yet another proinflammatory cytokine are in contrast to the numerous studies showing that IL-6 has beneficial effects on muscle metabolism [reviewed previously (29, 80, 86)].”
Result
Metadata
- Authors
- Glund, S., & Krook, A.
- Venue
- Acta Physiologica
- Publisher
- Wiley
- Published
- 2007-10-29
- Volume
- 192
- Issue
- 1
- Pages
- 37-48
- ISSN
- 1748-1708 (ISSN-L)
- 1748-1716
- OpenAlex
- W2155959568
- Cited by
- 126
- References
- 45
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.